RAI1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.758400E-01
Normal-vs-Stage2
8.304000E-01
Normal-vs-Stage3
9.083600E-02
Normal-vs-Stage4
4.837200E-01
Stage1-vs-Stage2
4.785200E-01
Stage1-vs-Stage3
9.588500E-02
Stage1-vs-Stage4
3.791400E-01
Stage2-vs-Stage3
1.432570E-01
Stage2-vs-Stage4
6.387000E-01
Stage3-vs-Stage4
3.585200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.966800E-01
Normal-vs-AfricanAmerican
7.499600E-01
Normal-vs-Asian
7.484400E-01
Caucasian-vs-AfricanAmerican
9.973800E-01
Caucasian-vs-Asian
3.614200E-01
AfricanAmerican-vs-Asian
5.124000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.313000E-01
Normal-vs-Female
8.531600E-01
Male-vs-Female
9.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.298000E-01
Normal-vs-Age(41-60Yrs)
7.184600E-01
Normal-vs-Age(61-80Yrs)
5.724800E-01
Normal-vs-Age(81-100Yrs)
4.277200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.097800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.823770E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.968790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.282100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.343900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.540200E-01
Normal-vs-Daily Drinker
7.070200E-01
Normal-vs-Weekly Drinker
7.762200E-01
Normal-vs-Occasional Drinker
5.994000E-01
Normal-vs-Social Drinker
7.032600E-01
Non Drinker-vs-Daily Drinker
9.016000E-01
Non Drinker-vs-Weekly Drinker
9.335200E-01
Non Drinker-vs-Occasional Drinker
1.171830E-01
Non Drinker-vs-Social Drinker
9.532200E-01
Daily Drinker-vs-Weekly Drinker
8.523200E-01
Daily Drinker-vs-Occasional Drinker
1.079620E-01
Daily Drinker-vs-Social Drinker
8.620200E-01
Weekly Drinker-vs-Occasional Drinker
1.501400E-01
Weekly Drinker-vs-Social Drinker
9.757400E-01
Occasional Drinker-vs-Social Drinker
1.258990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.052200E-01
Normal-vs-Grade 2
2.839200E-01
Normal-vs-Grade 3
1.855620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.921200E-01
Grade 1-vs-Grade 3
4.054600E-01
Grade 1-vs-Grade 4
4.052200E-01
Grade 2-vs-Grade 3
2.378000E-01
Grade 2-vs-Grade 4
2.839200E-01
Grade 3-vs-Grade 4
1.855620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.387000E-01
Normal-vs-NonDiabetic
9.976800E-01
Diabetic-vs-NonDiabetic
3.219700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.017000E-01
Normal-vs-NoPancreatitis
8.132400E-01
Pancreatitis-vs-NoPancreatitis
1.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.493000E-01
Normal-vs-N1
7.662400E-01
N0-vs-N1
7.435200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.350200E-01
Normal-vs-TP53-NonMutant
5.168000E-01
TP53-Mutant-vs-TP53-NonMutant
8.855600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
